1.宁夏医科大学中医学院,宁夏回族自治区银川市兴庆区胜利街1160号,750004
2.宁夏区域高发病中西医结合防治研究重点实验室
3.宁夏医科大学生育力保持教育部重点实验室
4.宁夏中医医院暨中医研究院
5.宁夏医科大学总医院宁夏干细胞与再生医学重点实验室
dxl_515@163.com
收稿:2023-02-13,
修回:2023-04-19,
纸质出版:2023-08-02
移动端阅览
陈苗,马会明,冯亚宏等.健脾益肾化浊方对多囊卵巢综合征模型大鼠卵巢颗粒细胞凋亡蛋白及PI3K/AKT/mTOR通路的影响[J].中医杂志,2023,64(15):1585-1592.
CHEN Miao,MA Huiming,FENG Yahong,et al.Effects of Jianpi Yishen Huazhuo Formula (健脾益肾化浊方) on Ovarian Granulosa Cell Apoptosis Protein and PI3K/AKT/mTOR Pathway in Polycystic Ovary Syndrome Model Rats[J].Journal of Traditional Chinese Medicine,2023,64(15):1585-1592.
陈苗,马会明,冯亚宏等.健脾益肾化浊方对多囊卵巢综合征模型大鼠卵巢颗粒细胞凋亡蛋白及PI3K/AKT/mTOR通路的影响[J].中医杂志,2023,64(15):1585-1592. DOI: 10.13288/j.11-2166/r.2023.15.013.
CHEN Miao,MA Huiming,FENG Yahong,et al.Effects of Jianpi Yishen Huazhuo Formula (健脾益肾化浊方) on Ovarian Granulosa Cell Apoptosis Protein and PI3K/AKT/mTOR Pathway in Polycystic Ovary Syndrome Model Rats[J].Journal of Traditional Chinese Medicine,2023,64(15):1585-1592. DOI: 10.13288/j.11-2166/r.2023.15.013.
目的
2
探讨健脾益肾化浊方治疗多囊卵巢综合征(PCOS)的可能作用机制。
方法
2
70只SD雌性大鼠随机分为空白组和模型组各15只,二甲双胍组,健脾益肾化浊方低、中、高剂量组各10只。除空白组外,其余各组均采用来曲唑灌胃联合高脂饲料喂养21天构建PCOS模型。造模成功后,空白组和模型组用10 ml/(kg·d)生理盐水灌胃;二甲双胍组用盐酸二甲双胍片100 mg/(kg·d)灌胃;健脾益肾化浊方低、中、高剂量组分别用健脾益肾化浊方药物混悬液1.275、2.55、5.10 g/(kg·d)灌胃,干预30天。将卵巢称重并计算卵巢指数;ELISA法测定大鼠血清促卵泡生成素(FSH)、促黄体生成素(LH)、睾酮(T)、抗苗勒管激素(AMH)和雌二醇(E
2
)水平;HE染色观察卵巢组织形态改变;免疫组织化学染色法检测大鼠卵巢组织半胱氨酸天冬氨酸酶3(Caspase-3)、半胱氨酸天冬氨酸酶9(Caspase-9)和磷脂酰肌醇-3激酶(PI3K)、蛋白激酶B(AKT)、哺乳动物雷帕霉素靶蛋(mTOR)蛋白阳性表达;Western blot法检测大鼠卵巢组织促凋亡蛋白(BAX)、抗凋亡蛋白(Bcl-2)、Caspase-9、细胞色素C(Cytochrome-C)和PI3K、AKT、mTOR蛋白相对表达。
结果
2
与空白组比较,模型组大鼠卵巢组织以囊性扩张卵泡为主,颗粒细胞层减少,间质增生明显;卵巢指数、血清T、LH、AMH、卵巢组织Caspase-3、Caspase-9平均光密度和BAX/Bcl-2值、Cytochrome-C、Caspase-9蛋白相对表达量明显升高,血清E
2
、FSH及卵巢组织PI3K、AKT、mTOR平均光密度和蛋白表达显著降低(
P
<0.05或
P
<0.01)。与模型组比较,健脾益肾化浊方各剂量组和二甲双胍组卵巢组织多囊样改变得到改善,可见各级卵泡和黄体,颗粒细胞层增厚,卵巢指数、血清LH、AMH、卵巢组织Caspase-9平均光密度和蛋白相对表达明显降低,血清E
2
、FSH,卵巢组织PI3K和AKT平均光密度,PI3K、AKT和mTOR蛋白相对表达显著升高(
P
<0.05或
P
<0.01);二甲双胍组和健脾益肾化浊方中、高剂量组血清T水平和Caspase-3平均光密度显著下降,健脾益肾化浊方低、高剂量组和二甲双胍组mTOR平均光密度显著增加、BAX/Bcl-2值明显降低,二甲双胍组和健脾益肾化浊方高剂量组卵巢组织Cytochrome-C蛋白表达显著降低(
P
<0.05或
P
<0.01)。与二甲双胍组相比,健脾益肾化浊方低剂量组血清T水平明显升高,健脾益肾化浊方中剂量组BAX/Bcl-2值显著升高(
P
<0.05);与健脾益肾化浊方中剂量组相比,健脾益肾化浊方高剂量组Cytochrome-C蛋白表达显著降低(
P
<0.05)。
结论
2
健脾益肾化浊方可抑制PCOS大鼠卵巢颗粒细胞凋亡蛋白表达,从而维持内分泌平衡以改善卵巢生殖功能,其机制可能与激活PI3K/AKT/mTOR信号通路有关。
Objective
2
To explore the possible mechanism of
Jianpi Yishen Huazhuo Formula
(健脾益肾化浊方, JYHF) in treating polycystic ovary syndrome (PCOS).
Methods
2
Seventy SD female rats were randomly divided into blank group and model group with 15 rats each, metformin group, JYHF low-, medium- and high-dose groups with 10 rats each. Except for the blank group, all the other groups were fed with letrozole orally combined with high-fat diet for 21 days to establish the PCOS model. After successful modeling, the blank group and the model group were intragastrically administered with 10 ml/(kg·d) of normal saline, while the metformin group was administered with 100 mg/(kg·d) of metformin hydrochloride tablets by gavage, and the JYHF low-, medium- and high-dose groups were administered intragastrically with 1.275, 2.55, and 5.10 g/(kg·d) of JYHF suspension respectively, all for 30 days. The ovaries were weighed and the ova-rian index was calculated, and serum follicle-stimulating hormone (FSH), luteinizing hormone (LH), testosterone (T), anti-Müllerian hormone (AMH) and estradiol (E
2
) levels were measured through ELISA. HE staining was used to observe the morphological changes of ovarian tissue. Immunohistochemical staining was used to detect caspase-3, caspase-9 and phosphatidylinositol-3 kinase (PI3K), protein kinase B (AKT), mammalian target of rapamycin (mTOR) protein positive expression. Western blot was performed to detect relative expressions of rat ovarian tissue pro-apoptotic protein (BAX), anti-apoptotic protein (Bcl-2), Caspase-9, Cytochrome-C, PI3K, AKT, and mTOR proteins.
Results
2
Compared to those in the blank group, the ovarian tissue of the rats in the model group was dominated by cystic dilated follicles, and the granulosa cell layer was reduced, with obvious interstitial hyperplasia; the ovarian index, serum T, LH, AMH, as well as Caspase-3 and Caspase-9 average optical density, BAX/Bcl-2 value, the relative expression of Cytochrome-C and Caspase-9 proteins significantly increased, while serum E
2
and FSH levels, average optical density and protein expression of PI3K, AKT, mTOR in ovarian tissue significantly decreased (
P
<0.05 or
P
<0.01). Compared to those in the model group, the polycystic changes of ovarian tissue in all JYHF groups and the metformin group were improved, with follicles and corpus luteum at all levels seen, and the granulosa cell layer thickened; the ovarian index, serum LH, AMH, average optical density and relative protein expression of Caspase-9 in the ovarian tissue were significantly reduced, while serum E
2
, FSH, ave-rage optical density of PI3K and AKT in the ovarian tissue, and relative protein expression of PI3K, AKT and mTOR significantly increased (
P
<0.05 or
P
<0.01). The serum T level and Caspase-3 average optical density in the metformin group and JYHF medium- and high-dose groups were reduced than those in the model gorup, while mTOR average optical density increased significantly, and BAX/Bcl-2 value decreased in the JYHF low- and high-dose groups and metformin group than the model group; the expression of Cytochrome-C protein in ovarian tissue significantly decreased in the metformin group and JYHF high-dose group (
P
<0.05 or
P
<0.01). Compared to the metformin group, the low-dose JYHF group had a significantly higher serum T level, and the medium-dose JYHF group had a significantly higher BAX/Bcl-2 value (
P
<0.05); the expression of Cytochrome-C protein in the high-dose JYHF group was significantly lower than that in the medium-dose group (
P
<0.05).
Conclusion
2
JYHF can inhibit the expression of apoptotic protein in ovarian granulosa cells of PCOS rats, thereby maintaining endocrine balance and improving ovarian reproductive function. The mechanism may be related to the activation of PI3K/AKT/mTOR signaling pathway.
FINSTERER J . Mitochondrial dysfunction in polycystic ovary syndrome [J]. Reprod Sci , 2023 , 30 ( 5 ): 1435 - 1442 .
袁莹莹 , 赵君利 . 多囊卵巢综合征流行病学特点 [J]. 中国实用妇科与产科杂志 , 2019 , 35 ( 3 ): 261 - 264 .
李康梅 , 戴明明 , 蒋越 , 等 . 卵泡发育不良的中医病因病机及中医药治疗研究进展 [J]. 中国医药导报 , 2020 , 17 ( 18 ): 37 - 40 .
郭浩洋 , 张思琪 , 王丽娜 , 等 . 多囊卵巢综合征伴胰岛素抵抗排卵障碍的中西医综合分析 [J]. 辽宁中医药大学学报 , 2023 , 25 ( 2 ): 197 - 200 .
孙淼 , 王玉艳 , 孟小钰 , 等 . 基于“肾虚、痰湿、血瘀”的现代生物学基础探讨PCOS中医病机的科学内涵 [J]. 时珍国医国药 , 2022 , 33 ( 6 ): 1412 - 1415 .
冯亚宏 , 张晓静 , 杜翠忠 . 健脾益肾化浊方治疗肥胖型多囊卵巢综合征60例临床观察 [J]. 母婴世界 , 2021 , 21 ( 1 ): 100 .
PENG SL , WU QF , XIE Q , et al . PATL2 regulated the apoptosis of ovarian granulosa cells in patients with PCOS [J]. Gynecol Endocrinol , 2021 , 37 ( 7 ): 629 - 634 .
ROBERTS JA , CARPENTER RM , BLYTHE SN , et al . FSH/AMH ratio and adipocyte size are linked to ovarian dysfunction [J]. Endocr Res , 2020 , 45 ( 3 ): 174 - 189 .
陈翠 , 徐传花 . PI3K/AKT/mTOR通路参与多囊卵巢综合征患者子宫内膜病变的研究进展 [J]. 中医药通报 , 2022 , 21 ( 8 ): 57 - 60 .
XU Z , HAN X , OU D , et al . Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy [J]. Appl Microbiol Biotechnol , 2020 , 104 ( 2 ): 575 - 587 .
尹萍 , 路璐 , 陈媛媛 , 等 . 来曲唑联合45%高脂饲料诱导生殖内分泌及代谢表型异常的多囊卵巢综合征大鼠模型研究 [J]. 药学实践杂志 , 2019 , 37 ( 5 ): 422 - 426 .
黄千千 , 王娇剑 , 宋殿荣 . 多囊卵巢综合征鼠类动物模型的构建 [J]. 国际妇产科学杂志 , 2022 , 49 ( 3 ): 261 - 266,277 .
李晓 , 胡亦明 , 韦春昕 , 等 . 基于Wnt/β-catenin信号通路探讨黑逍遥散对AD模型大鼠神经炎症的影响 [J]. 中国实验方剂学杂志 , 2022 , 28 ( 11 ): 33 - 41 .
史昭 , 高媛 , 魏绍斌 . 魏绍斌治疗多囊卵巢综合征性不孕症经验介绍 [J]. 中医药临床杂志 , 2018 , 30 ( 9 ): 1624 - 1626 .
常珍珍 , 王金权 , 乔丽 , 等 . 王氏益经汤联合常规疗法治疗多囊卵巢综合征肾虚痰湿证的疗效及对肠-脑轴调节作用 [J]. 中国实验方剂学杂志 , 2022 , 28 ( 13 ): 145 - 151 .
冉雪梦 . 基于窠囊论治肥胖型多囊卵巢综合征 [J]. 中医药通报 , 2022 , 21 ( 4 ): 29 - 31 .
李樊 , 李隐侠 , 舒嘉傲 , 等 . 热应激通过钙信号调控湖羊卵巢颗粒细胞凋亡和雌激素合成 [J]. 江苏农业学报 , 2022 , 38 ( 5 ): 1278 - 1285 .
毕晓英 , 许珂 , 赵艳晓 , 等 . 基于PI3K/AKT/mTOR通路研究杜仲总黄酮对多囊卵巢综合征大鼠性激素水平及卵巢组织自噬的影响 [J]. 中药药理与临床 , 2022 , 38 ( 1 ): 82 - 86 .
张萍 , 王维斌 , 邵岩飞 , 等 . 二陈汤对多囊卵巢综合征大鼠卵巢组织Bcl-2及Bax蛋白表达的影响 [J]. 北京中医药大学学报 , 2020 , 43 ( 11 ): 941 - 950 .
WANG M , XIA L , FU G . Lipopolysaccharide pretreatment inhibits oxidative stress-induced endothelial proge-nitor cell apoptosis via a TLR4-mediated PI3K/Akt/NF-κB p65 signaling pathway [J]. Cell Mol Biol (Noisy-le-grand) , 2019 , 65 ( 4 ): 101 - 106 .
QIU Z , DONG J , XUE C , et al . Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway [J]. J Ethnopharmacol , 2020 , 250 : 111965 . doi: 10.1016/j.jep.2019.111965 http://dx.doi.org/10.1016/j.jep.2019.111965 .
XIONG H , HU Q , JIANG Q . Protective effects of lidocaine on polycystic ovary syndrome through modulating ovarian granulosa cell physiology via PI3K/AKT/mTOR pathway [J]. Cytotechnology , 2022 , 74 ( 2 ): 283 - 292 .
王毅 , 王海娇 , 祁麟 , 等 . 桃核承气汤对多囊卵巢综合征大鼠卵巢组织PI3K/AKT/mTOR信号通路的影响 [J]. 天津医药 , 2023 , 51 ( 6 ): 596 - 601 .
李建南 , 于凤英 , 沈欢欢 , 等 . 桂枝茯苓丸联合西医药物治疗多囊卵巢综合征的疗效及对PI3K/AKT/mTOR通路的调节作用 [J]. 分子诊断与治疗杂志 , 2023 , 15 ( 2 ): 197 - 200,204 .
0
浏览量
1
下载量
5
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号